Previous 10 | Next 10 |
Evolent Health (NYSE:EVH) to acquire Georgia-based IPG, a leading technology and services company providing surgical management solutions for musculoskeletal conditions, from TPG Growth for $375 million in cash plus additional contingent consideration of up to $87 million. The move diver...
EVOLENT HEALTH TO ACQUIRE IPG PR Newswire - Expected to Accelerate Evolent Health's Position as a Leading Provider of Value-Based Specialty Care Solutions - Expands Evolent's Value-Based Specialty Care Solutions Portfolio to Musculoskeletal Conditions - Exp...
Predictive markets response to current equity price comparisons of this stock pair suggests value attraction for EVH and further decline in MPW. Prior reward~risk coming price-range forecasts like the present have produced for MPW average holding outcomes of only +0.1% price gains ins...
The following slide deck was published by Evolent Health, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Evolent Health, Inc. 2022 Q1 - Results - Earnings Call Presentation
Image source: The Motley Fool. Evolent Health (NYSE: EVH) Q1 2022 Earnings Call May 04, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Evolent Health (EVH) Q1 2022 Earnings Call Transcript
Evolent Health, Inc. (EVH) Q1 2022 Earnings Conference Call May 4, 2022, 5:00 PM ET Company Participants Seth Blackley – Chief Executive Officer John Johnson – Chief Financial Officer Seth Frank – Vice President of Investor Relations Conference Call Participants Richard C...
Evolent Health press release (NYSE:EVH): Q1 Non-GAAP EPS of $0.12 beats by $0.13. Revenue of $297.06M (+38.1% Y/Y) beats by $10.25M. Full Year 2022 Guidance Revenue for the year ending December 31, 2022 is expected to be in the range of approximately $1.16 billion to $1.21 billion. Analysts e...
Evolent Health Announces First Quarter 2022 Results PR Newswire Announces Two Operating Partner Additions and One Expansion WASHINGTON , May 4, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clini...
Evolent Health (NYSE:EVH) is scheduled to announce Q1 earnings results on Wednesday, May 4, after market close. The consensus EPS estimate is -$0.01 (flat Y/Y) and the consensus revenue estimate is $286.81M (+33.4% Y/Y). Over the last 2 years, EVH has beaten EPS estimates 50% of the time and ...
Evolent Health, Inc. to Release First Quarter Operating Results and Host Conference Call on Wednesday, May 4, 2022 PR Newswire WASHINGTON , April 18, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinica...
News, Short Squeeze, Breakout and More Instantly...
Evolent Health Inc Class A Company Name:
EVH Stock Symbol:
NYSE Market:
Evolent Health Inc Class A Website:
Evolent To Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024 PR Newswire Company to Participate in Upcoming Conferences WASHINGTON , July 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in bett...
Evolent signs agreement to acquire artificial intelligence utilization management products and team from Machinify PR Newswire Machinify solution seeks to accelerate the efficiency, quality, and clinical value of Evolent's specialty condition management platform through AI-e...
2024-05-09 22:30:13 ET Image source: The Motley Fool. Evolent Health (NYSE: EVH) Q1 2024 Earnings Call May 09, 2024 , 5:00 p.m. ET Operator Continue reading For further details see: Evolent Health (EVH) Q1 2024 Earnings Call Transcript